慢加急性肝衰竭:更新
慢加急性肝衰竭(ACLF)是慢性肝病急性失代偿伴器官衰竭和高短期死亡率的综合征,酒精和慢性病毒性肝炎是最常见的基础肝病,40%-50%病例无可识别诱因,全身炎症反应过度似起关键作用,采用肝脏适配的序贯器官衰竭评估评分可对患者进行分诊和预后判断,病程动态变化,入院第3-7天可明确预后并据此调整肝移植评估或治疗目标讨论等临床决策,生物人工肝支持系统、粒细胞集落刺激因子或干细胞移植尚在探索阶段,数据尚不成熟不足以作为标准治疗实施。
要点
- ACLF是慢性肝病急性失代偿伴器官衰竭和高短期死亡率的综合征。
- 酒精和慢性病毒性肝炎是最常见的基础肝病,40%-50%病例无可识别诱因。
- 采用肝脏适配的序贯器官衰竭评估评分可对ACLF患者进行分诊和预后判断。
核心结论
- ACLF是慢性肝病急性失代偿伴器官衰竭和高短期死亡率的综合征,全身炎症反应过度似在ACLF发生中起关键作用,采用肝脏适配的序贯器官衰竭评估评分可对患者进行分诊和预后判断,病程动态变化,入院第3-7天可明确预后并据此调整临床决策。
- 生物人工肝支持系统、粒细胞集落刺激因子或干细胞移植尚在探索阶段,数据尚不成熟不足以作为标准治疗实施。
研究设计与样本
- 综述,未报告系统检索范围。
主要发现
- 酒精和慢性病毒性肝炎是ACLF最常见的基础肝病。
- 高达40%-50%的ACLF病例无可识别诱因;其余患者中脓毒症、活动性酒精滥用和慢性病毒性肝炎复发是最常报告的诱发因素。
- 全身炎症反应过度似在ACLF发生中起关键作用。
- ACLF病程动态变化,在住院期间不断变化,多数患者入院第3天至第7天可明确预后。
关键数值与推荐
- 采用肝脏适配的序贯器官衰竭评估评分可对ACLF患者进行分诊和预后判断。
临床怎么用
- 临床决策如肝移植评估或治疗目标讨论可借助临床评分进行个体化调整。
- 生物人工肝支持系统、粒细胞集落刺激因子或干细胞移植数据尚不成熟,不足以作为标准治疗实施。
局限性
- 生物人工肝支持系统、粒细胞集落刺激因子或干细胞移植数据尚不成熟,不足以作为标准治疗实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute-on-chronic liver failure (ACLF) is a syndrome characterised by acute decompensation of chronic liver disease associated with organ failures and high short-term mortality. Alcohol and chronic viral hepatitis are the most common underlying liver diseases. Up to 40%-50% of the cases of ACLF have no identifiable trigger; in the remaining patients, sepsis, active alcoholism and relapse of chronic viral hepatitis are the most common reported precipitating factors. An excessive systemic inflammatory response seems to play a crucial role in the development of ACLF. Using a liver-adapted sequential organ assessment failure score, it is possible to triage and prognosticate the outcome of patients with ACLF. The course of ACLF is dynamic and changes over the course of hospital admission. Most of the patients will have a clear prognosis between day 3 and 7 of hospital admission and clinical decisions such as evaluation for liver transplant or discussion over goals of care could be tailored using clinical scores. Bioartificial liver support systems, granulocyte-colony stimulating factors or stem-cell transplant are in the horizon of medical care of this patient population; however, data are too premature to implement them as standard of care.
引用
- Hernaez R, Solà E, Moreau R, et al. Acute-on-chronic liver failure: an update. Gut. 2017. PMID: 28053053. doi:10.1136/gutjnl-2016-312670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。